Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03921 |
| Species: | Homo sapiens |
| Position : | chr10:79285696-79287696 |
| Year: | 2021 |
| Title: | Genome-wide enhancer maps link risk variants to disease genes. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | inflammatory bowel disease |
| PMID: | 33828297 |
| MONDO: | MONDO:0005265 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | THP-1 |
| CVCL ID: | CVCL_0006 |
| Cell Type: | monocyte |
| Cell Ontology ID: | CL:0000576 |
| Experiment Type: | Functional perturbation assay; enhancer-target validation; Disease-variant functional analysis |
| High Throughput Method: | CRISPRi-FlowFISH; GWAS |
| Low Throughput Method: | Individual CRISPRi; RT-qPCR; MitoTracker membrane-potential assay |
| Target gene : | PPIF |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|